TransDigm Group COO amends 3,900-share option filing
TransDigm Group executive Joel Reiss, Co-Chief Operating Officer, reported exercising stock options covering 3,900 shares of common stock on July 15, 2026 at an exercise price of $284.97 per share, leaving 11,900 options outstanding.
Rhea-AI Filing Summary
TransDigm Group executive Joel Reiss, Co-Chief Operating Officer, reported exercising stock options covering 3,900 shares of common stock on July 15, 2026 at an exercise price of $284.97 per share, leaving 11,900 options outstanding. The amended filing corrects the coding of this derivative transaction from an acquisition to a disposition and indicates it was effected under a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1 | 3,900 | $0.00 | $0.00 |
Footnotes (1)
- F1. This Form 4/A amends the Form 4 originally filed on 07.16.2026 to correct the reporting of the transaction in Table II, which was inadvertently reported as an acquisition ('A') rather than a disposition ('D'). No other changes have been made to the original filing.
Key Figures
Key Terms
Form 4/A regulatory
disposition regulatory
derivative security financial
Stock Option financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did TransDigm (TDG) Co-Chief Operating Officer Joel Reiss report in this Form 4/A amendment?
Why did TransDigm (TDG) file an amended Form 4/A for Joel Reiss’s option transaction?
How many TransDigm (TDG) stock options does Joel Reiss hold after the reported transaction?
At what price were the TransDigm (TDG) stock options exercised in Joel Reiss’s amended Form 4/A?
Was Joel Reiss’s TransDigm (TDG) option transaction made under a Rule 10b5-1 trading plan?
What type of security is involved in the TransDigm (TDG) Form 4/A filed for Joel Reiss?
AI-generated analysis. How Rhea-AI works. Not financial advice.